Key result
Chronic oral ISDN demonstrates a prolonged terminal half-life of ~7.7 hours in CAD.
Why the study?
Does chronic oral isosorbide dinitrate 60 mg result in a prolonged plasma half-life in patients with coronary artery disease?
Does chronic oral isosorbide dinitrate 60 mg result in a prolonged plasma half-life in patients with coronary artery disease?
Answers are grounded in this paper and cite their sources.
The prolonged terminal half-life of 7.7 hours for oral isosorbide dinitrate provides a partial explanation for its plasma accumulation after chronic 6-hourly dosing.
The plasma concentration of isosorbide dinitrate (ISDN) was monitored up to 24 h after a chronic oral dose of 60 mg in six patients with coronary artery disease. A terminal half-life of 7.7 +/- 2.6 h (mean +/- s.d.) was observed. The presence of this prolonged disappearance phase provided at least a partial explanation for the observed accumulation of ISDN in plasma after chronic dosing on a six hourly regimen.
No takes yet. Share an insight, caveat, or question.
Fung et al. (1983) studied Coronary artery disease / Angina pectoris (n=6). Isosorbide dinitrate (ISDN) was evaluated on Terminal half-life. A chronic oral dose of isosorbide dinitrate in patients with coronary artery disease demonstrated a prolonged terminal half-life of 7.7 +/- 2.6 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: